Q3 2024 saw a 39% sales decline and negative operating profit, mainly due to North American challenges, while Asia met expectations. Regulatory approvals and new hires are expected to support a return to growth.
Original document:
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.